Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
US fulfillment: Domestic synthesis and faster shipping cut customs delays
Lack of FDA regulation: This raises safety and consistency concerns
The FDA told MEDVi that its site falsely suggested MEDVi was the compounder of the semaglutide and tirzepatide it sold, and that claims like Same active ingredient as Wegovy and Ozempic and Same active ingredient as Mounjaro and Zepbound falsely implied FDA approval or evaluation
As with all research peptides, proper storage, handling, and compliance with research-use-only guidelines are essential.
US$ 23.72
US$ 28.53
US$ 29.13
US$ 23.85
US$ 28.67
US$ 24.46
